@mikkaelsekeres : In my 5 years on ODAC, attended a small handful of meetings where we voted “no” for a drug and ⁦@US_FDA⁩ approved the drug anyway, but never where we almost uniformly (150-0-1) opposed a drug like Aducanumab for Alzheimer’s. nytimes.com/2021/06/10/hea… • TwiCopy

Mikkael A. Sekeres MD, MS

@mikkaelsekeres

+ Follow

Chief, Division of Hematology @SylvesterCancer @UMiamiHealth | Clinical scientist, essayist | Author @mitpress | Chair @ASH_hematology Communications | My views

ID: 390846254

linkhttp://www.mikkaelsekeres.com calendar_today14-10-2011 16:58:41

5,5K Tweet

9,9K Followers

457 Following

Mikkael A. Sekeres MD, MS

@mikkaelsekeres

3 years ago

In my 5 years on ODAC, attended a small handful of meetings where we voted “no” for a drug and ⁦U.S. FDA⁩ approved the drug anyway, but never where we almost uniformly (10-0-1) opposed a drug like Aducanumab for Alzheimer’s. nytimes.com/2021/06/10/hea…